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stimulants to restore the immunosuppression that accompanies sepsis. 
Unfortunately, it remains difficult to identify those patients who 
benefit from anti-cytokine therapies in septic shock and those who 
do not. For example, a recent trial of NMMA (blacking the synthesis 
of nitric oxide, NO)  resulted in a greater mortality than with placebo. 
Thus, there are patients who should not receive anti-cytokine 
therapy, as this also reduces NO synthesis. 
Molecular methods for the diagnosis of 
infectious diseases 
ml Direct visualization of microorganisms by 
fluorescence in situ hybridization 
A. Moter. ~iniversit&tsklinikrm Charitl, Mikrobiologie rind Hy‘qiene, 
Berlin, Germany 
The  ultimate goal oE diagnostic microbiology is the rapid and 
accurate identification of bacteria in their natural environments. 
Fluorescence in situ hybridization (FISH) allows molecular detection 
of niicroorganisnis on a single-cell level. It therefore provides 
additional plausibility by involving morphologic criteria. Further- 
more, the analysis of surrounding cells and tissues becomes possible. 
The  most commonly used target for probes used in microbiology is 
ribosoiiial 16s RNA.  Fluorescence-labeled D N A  fragments or 
oligonucleotxdes applied as a probe to tissue and smear preparations 
enable the visualization of bacteria by a single hybridization step 
within a couple of hours. Probes have been successfully used for the . 
identification of hitherto uncultured microorganisms. Being faster 
than cultivation methods and cheaper than PCR-based methods, 
FISH has the potential to become a useful tool in environmental, 
medical and veterinary medicine. However, a number of difficulties 
and pitfalls have to be considered. Experience and careful controls 
arc crucial for the interpretation of results and its future application 
in medical dia&mosis. 
w] High-density oligonucleotide arrays 
A. Troesch. Mnrcy-I’Etoilt., Pork, France 
The Genechip technology, developed by Affyrnetrix, is a promising 
new method for assessing genetic diversity on a larger scale. This 
technology, which relies upon hybridization of the nucleic acid target 
with tens to hundreds of thousands of oligonucleotides synthesized 
on  a ininiaturized glass support, is expected to have extensive appli- 
cations in infectious disease diagnostics. We have investigated this 
probe array strategy both for bacteriology and virology testing and 
have designed specific probe arrays for: (1) identification of niyco- 
bacteria species and detection of mutations associated with antibiotic 
resistance in Mycohacteriimz tuberculosis; and (2)  monitoring of the 
emergence of antiviral drug resistance in HIV. Hybridization on the 
arrays, scanning and data analysis can be performed in 1 h. The  
mycobacterium probe array has been validated on  an extensive panel 
of Mycobacterium strains and rifampin-resistant Mycobacterium 
ruberculosis isolates. The  feasibility of drug resistance detection in HIV 
has been demonstrated for various mutations located on the protease 
and reverse transcriptase genes. Overall, this new technology opens 
new perspectives in terms of patient management for infectious 
diseases, by allowing a number of genetic tests to be run sirnul- 
taneonsly The principle of the technology, validation results and 
potential diagnostic applications of probe arrays will be discussed. 
wl Identification of uncultured bacteria 
U. Gobe.1. bistiturJur Milerohioloyie und Hyqietie, Berliri, C;(WIOJI), 
Currently we are witnessing a transition from culture-based detection 
to growth-itidrpendent niolecular identification of i i i icr~~~~r~i i i is i i is .  
Special protocols have been developed to enrich and analyze q 3 t ~ i n l  
genes or transcripts. The most widespread technique used in bactcrio- 
loby is the comparative analysis of ribosomal rKNA gciic\ oi- 
fragments thereof. The architecture and the ubiquitous nature of this 
molecule allow rapid and unequivocal identification of not ciiily 
cultured but also uncultured bacteria, including iiovel bdcteri‘i in 
coiiiplex environmental habitats as well ~s novel emerging pathogen?. 
Advantages and pitfalls of this technique are discuwd. 
wl Methods for ultra-sensitive detection and 
quantitation of genes and mRNA 
€? Williams. Antibody and Bionssay T r c / i ~ i ~ / o < ~ ) :  7?c/iriolq~y (;rricwtcc/i 
luc , ,  SOJ~ Frafzcisco, CA, USA 
Several approaches have been tdken for ultra-sensitive detection of 
specific nucleic acid sequences: (1) signal amplification mrthod\ and 
( 2 )  target amplification methods. Most traditional nuclcic acid 
detection methods rely on  isotopic probes in order to detcct 
sequences of interest in a biological sample. Recently, a iiiultitudc o t  
non-isotopic methods have been ciiiployed, relying o n  ei~zyiiiatic 
amplification of a signal. One such appi-oach, branched DNA (b- 
DNA; Chiron Diagnostics), provides a very sensitive and quantit.itive 
detection method. A description of this technique and its ,ipplicntion 
to quantitative inKNA studies will be dejcribed. The advcnt of  the 
polyinerase chain reaction (PCR), a tarset miplificatiwi nicthod, hAs 
also permitted very sensitive detection of nucleic acid tcqueiicc\. 
Attempts to develop quantitative applications of I’CR u c  hindcrcd 
by several obstacles inherent in the methodoloby The development 
of ‘real-time quantitative PCR’ has largely overconic many of the 
obstacley. A description of the ‘real-tinic quantitative l’Cl<’ tiiethod 
and applications will be presentcd. Finally, tlic topic\ of saiiplc 
preparation, assay design and interpretation of quantitative ineawrr- 
ments of nucleic acid sequences will addressed 
F l  Spoligotyping in the epidemiology of 
tuberculosis 
J. van Embden, T. van Gorkoni, K. Kreiiier, L. Schoul\. Labiiruriiry 
j r  Irfertious Disease Research, Nntiorlal Itistitute of Priblic Hedlrli mi i f  
the Eiwiroiirwut, Bilthuven, The Netherlarids 
Mycohaclerium tuberculosis complex strain5 contain an unusual genetic 
DNA locus carrying multiple direct repeats (DRs) of 36 base pair\, 
which are spaced by non-repetitive DNA spacers of similar s~ze. The 
sequence of the I I R  is specific for 12.1. rubertulosis complex bacteria 
and therefore the D R  locus is an excelleiit multicopy t q e t  for I ’ C X  
detection of pathogenic mycobacteria. l h r  to the strain-depcndeiit 
absence or  presence of spacers we have developed .I rapid niethod 
(spacer ohgotyping or spoligotyping) to differentiate clinical ~tolates 
for the epidemiology of tuberculosis. Spoligotpying can be carried 
out directly on  clinical material and on stained microscopic s l ~ d e ~ ,  
thus allowing siniultaiirous detection and strain typmg of M. 
tirherculosis complex bacteria in clinical saniples. In an nttennpt to 
increase the level of strain differentiation by spoligotyping and to get 
insight into the nature of the I3R-associated DNA polymorphi\ni, 
we have sequenced 13R loci in various clinical isolate\. More than 60 
different spacers have been identified and .Vl. h i s ,  M. tnirroti .md .\I 
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canetti each carry a species-specific combination of spacers, allowing 
easy recognition of these species by spoligotyping. The function of 
the DR locus is unknown, but not essential for growth, as DR 
knockout mutants are viable. The existence of D R  loci in other 
bacterial species and their potentlal use in epidemiology will be 
discussed. 
Resistant bacteria-their evolution and 
pharmacodynamic response to 
antimicrobials 
Fitness costs of resistance and genetic 
compensation 
D. Anderson. Suedish Institute f o r  Infectious Diseases Control, Solna, 
Sweden 
The rate of development and stability of antibiotic resistance are 
determined by several factors, most of which have not been studied 
in any detail. For example, bacterial population sizes, mutation rates, 
antibiotic concentration heterogeneities in hosts, fitness costs of 
resistance, and the ability of bacteria to genetically compensate for 
such costs, are factors that will affect resistance dynamics. Of parti- 
cular interest are fitness costs and the amelioration of these costs by 
compensatory mutations. We have studied several types of chromo- 
somal resistances (due to target modifications) in several species of 
pathogenic bacteria. Results show that in most cases resistant bacteria 
are less fit, both in animal models and under laboratory conditions. 
However, this picture is con~plicated by the rapid appearance of 
compensatory mutations that restore fitness without loss of resistance. 
Thus, compensatory mutations could stabilize a resistant population 
and make resistance irreversible. 
Combination therapy as a tool to prevent 
emergence of resistance. What can be learnt 
from in vitro models? 
J.W. Mouton. Cunisius USlhelmina Hospital, Dept. ofMicrobiology, 
Ni jmepn,  The  Netherlands 
One of the possible strategies to prevent emergence of resistance is 
the use of combination therapy. In vitro pharmacokinetic models can 
be used to simulate various dosing regimens of the combinations, 
both to determine the optimal regimens to be used and to obtain 
insight into the selection process of resistant bacteria during those 
regimens. Most of the (few) studies performed show that, if resistance 
emerges during monotherapy, this can be prevented by the use of a 
combination. Experiments where Pseudomonus aenrginosa is treated 
with beta-lactani-aminoglycoside combinations indicate that this 
could be partly due to the supplementary kill by the aminoglycoside 
reducing the inoculum. The same conclusions can be drawn for the 
quinolone-beta-lactam combinations. By using inocula of two 
different strains with different MICs in various proportions, more 
insight is gained into this process. 
Progress in meningitis 
From gene to disease: the example of 
pneumococcal meningitis 
E. Tuomanen. S t l u d e  (ChiIdrenS Research) Hospital, Memphis, TN, 
USA 
The pneuinococcus adheres to activated blood-brain barrier 
endotheliaI cells via the PAF receptor, an interaction that enables 
endocytosis to occur. This route of entry to the central nervous 
system (CNS) involves a novel recyling route of trafficking and 
depends on the bacterial surface protein, CbpA. Expression of this 
protein is highly regulated. The bacteria transit cells of the cerebral 
microvasculature within a vacuole without intracellular multiplica- 
tion and enter the cerebrospinal fluid space. 
Death of glia and neurons is responsible for the sequelae of disease. 
Pneumolysin, a potent cytotoxin in the lung, is not required for this 
process in the CNS. Injury in the hippocampus I is prominent and 
involves caspase activation and classical apoptosis. This is particularly 
evident in the dentate gyrus, and neuronal and microglial cell death 
is attenuated in a rabbit meningitis model by inhibitors of caspase 
activation. The apoptosis requires participation of elements of the 
host inflammatory response. Other areas of the bran undergo a 
second type of apoptotic mechanism driven by the pneumococcus. 
Thus, preventing sequelae of pneumococcal meningitis may involve 
antibiotics and addition of apoptosis inhibitors in conjunction with 
down-modulation of inflammation. 
Prevention of infections in 
immunocompromised patients 
[s1061 Prevention of bacterial infections in cancer 
patients 
C. Viscoli. University of Genoa, Institutefor Cancer Research, Genoa, 
Italy 
Several procedures (from reverse isolation to total protective isolation 
with LAF rooms) have been proposed for the prevention of infection 
in cancer patients. However, most of these procedures are not cost- 
effective, so that standard precautions, including careful hand- 
washing and appropriate management of IV lines, remains the only 
effective method for preventing bacterial infections in this patient 
population. Isolation measures should rather be aimed at preventing 
the spread of transmissible diseases or multiresistant organisms within 
the hospital. Chemoprophylaxis with non-absorbable (total or 
selective intestinal decontamination) and absorbable antibiotics 
(selective decontamination+systemic prophylaxis) has also been 
studied and used extensively. Poor compliance, risk of recolonization 
with resistant organisms, development of resistance and lack of 
efficacy on pragmatic endpoints are common problems encountered 
with chemoprophylaxis. The most popular drugs that have been used 
(and are still used) are the Auoroquinolones. Indeed, these drugs were 
shown to provide a consistent reduction in the incidence of Gram- 
negative bacteremia, although with no effect on, or even an causing 
an increase in, Gram-positive bacteremia. Moreover, almost no study 
showed any effect on ‘strong’ endpoints, such as mortality, fever and 
need to use IV antibiotics. Finally, resistance to fluoroquinolones 
started to spread rapidly, especially amongst E. coli and staphylococci. 
Cancer patients are not all the same and high-risk patients might have 
benefited (and might still benefit) from prophylaxis. Unfortunately, 
